Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.71 - $19.57 $468 - $3,385
173 Added 0.39%
44,561 $126,000
Q4 2023

Feb 13, 2024

BUY
$12.07 - $18.46 $78,080 - $119,417
6,469 Added 17.06%
44,388 $653,000
Q3 2023

Nov 14, 2023

SELL
$18.08 - $23.45 $97,415 - $126,348
-5,388 Reduced 12.44%
37,919 $694,000
Q2 2023

Aug 21, 2023

BUY
$20.98 - $31.42 $514,954 - $771,203
24,545 Added 130.82%
43,307 $934,000
Q1 2023

May 09, 2023

SELL
$27.71 - $40.93 $37,934 - $56,033
-1,369 Reduced 6.8%
18,762 $550,000
Q4 2022

Feb 14, 2023

BUY
$29.75 - $39.26 $184,688 - $243,726
6,208 Added 44.59%
20,131 $743,000
Q3 2022

Nov 18, 2022

BUY
$17.15 - $30.92 $154,658 - $278,836
9,018 Added 183.85%
13,923 $392,000
Q2 2022

Aug 15, 2022

BUY
$6.85 - $19.93 $5,610 - $16,322
819 Added 20.04%
4,905 $94,000
Q1 2022

May 16, 2022

BUY
$12.85 - $32.9 $52,505 - $134,429
4,086 New
4,086 $53,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $310M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.